American Journal of Epidemiology Advance Access originally published online on August 24, 2005
American Journal of Epidemiology 2005 162(7):704-705; doi:10.1093/aje/kwi265
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Copyright © 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved
LETTERS TO THE EDITOR |
THE USE OF PROSTATE-SPECIFIC ANTIGEN AS A CRITERION FOR CONDOM EFFECTIVENESS
1 Institute of Pathology, Comenius University School of Medicine, 811 08 Bratislava, Slovakia
2 Department of Microbiology and Immunology, University of Arizona College of Medicine, and the Arizona Cancer Center, Tucson, AZ 85724-5049
| The first 10% of the full text of this article appears below. |
A series of articles recently published in the Journal (1
4
) reported on the use of pre- and postcoital levels of prostate-specific antigen (PSA) in vaginal fluid as a criterion for the effectiveness of condoms. The authors of course emphasized and interpreted the absence of PSA in the vagina as
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. M. Hobbs, M. J. Steiner, P. J. Feldblum, and N. Padian HOBBS ET AL. REPLY Am. J. Epidemiol., October 1, 2005; 162(7): 706 - 706. [Full Text] [PDF] |
||||
![]() |
M. Macaluso, M. L. Lawson, and D. L. Warner MACALUSO ET AL. REPLY Am. J. Epidemiol., October 1, 2005; 162(7): 705 - 705. [Full Text] [PDF] |
||||
